Annexin Pharmaceuticals AB (publ)

📍 Stockholm, Sweden🗓 Founded 2014👥 11 employees💰 Last funded May 2018
Biotechnology🌐 annexinpharma.com
Website LinkedIn
Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company in the Annexin A5 field, for the treatment of various cardiovascular diseases. The Company’s biological drug candidate ANXV – a human recombinant protein, Annexin A5 – is intended primarily for the acute treatment of patients with cardiovascular diseases with vascular damages and inflammation. The Company also has a comprehensive patent portfolio for the treatment of diseases caused by vascular damage and inflammation. Annexin Pharmaceuticals has established and optimized a cell line for large-scale production of Annexin A5. The production process is patented. ANXV has the ability to protect and repair the blood vessels as well as counteract the inflammation. ANXV is therefore expected to reduce suffering and hopefully mortality for several patient groups with both rare vascular diseases and major ones, such as heart attack. ANXV has the potential to become a First-In-Class drug (a product with new and unique mechanisms of action which is the first of its kind on the market) for several patient groups where there is considerable unmet demand for medical treatment.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Annexin Pharmaceuticals AB (publ)?
Annexin Pharmaceuticals AB (publ) has 2 investors on record on gritt.io, 2 mid-stage.
When did Annexin Pharmaceuticals AB (publ) last raise funding?
The most recent investment in Annexin Pharmaceuticals AB (publ) recorded on gritt.io was in May 2018.
When was Annexin Pharmaceuticals AB (publ) founded?
Annexin Pharmaceuticals AB (publ) was founded in 2014.
What industry is Annexin Pharmaceuticals AB (publ) in?
Annexin Pharmaceuticals AB (publ) operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Annexin Pharmaceuticals AB (publ) based?
Annexin Pharmaceuticals AB (publ) is headquartered in Stockholm, Sweden.